Module 1 of 5
The IDE framework
What Part 812 covers, what is exempt, and the basic rules for investigational devices.
Lecture for Module 1. Open the playlist on YouTube
Key points
- Part 812 applies to clinical investigations of devices to determine safety and effectiveness (812.2(a)).
- A device found substantially equivalent to a pre-May 28, 1976 device, and used per the labeling FDA reviewed, is exempt, except 812.119 (812.2(c)(2)).
- Certain noninvasive diagnostic device studies are exempt when diagnosis is confirmed by an established method (812.2(c)(3)).
- An investigational device carries the "investigational use" caution statement (812.5(a)).
- Promoting or test marketing an investigational device is prohibited (812.7).
- IRBs reviewing device studies comply with Part 56; consent follows Part 50 (812.60, 812.100).
Reading for this module
- 21 CFR 812.2 and 812.3, Applicability and definitionsScope, exemptions (812.2(c)) and definitions (812.3).
- 21 CFR 812.5 and 812.7, Labeling and prohibitionsInvestigational labeling and prohibited promotion.
Module 1 quiz
10 questions. Pass mark: 9 of 10. Questions and answers are shuffled each time, and you see the explanations when you finish.